Active, Not Recruiting
Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT05807880
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China